Peptides are a selective, efficacious, and unique class of molecules that bind to specific cell surface receptors, triggering intracellular effects. They are short chains of amino acids linked by a peptide bond. Although they are molecularly poised between small molecules and proteins, peptides have distinctive therapeutic and biochemical properties. They represent an attractive first step in developing novel therapeutics across different areas, including oncology, metabolic, cardiovascular, infectious, endocrine, neurology, and other disorders. For decades, researchers have endeavored to comprehend intracellular protein-protein interactions (PPIs) as they play a critical role in the pathogenesis of numerous disease states. The development of constrained peptides exhibits an emerging approach that addresses challenging PPIs.

1. Definition 

2. Research Scope 

3. Research Methodology 

4. Markets Overview 

5. Characteristics of Conformationally Constrained Peptides

6. Pipeline

7. Impact of COVID-19 on Global Constrained Peptide Drugs Market

8. Industry Insights 

9. Market Dynamics